Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    16525139 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Ara-C;   Drug: BCNU;   Drug: Cisplatin;   Drug: Cytoxan;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Filgrastim;   Drug: Recombinant GM-CSF;   Drug: Interferon-alpha-2b;   Drug: Melphalan;   Drug: Vincristine
2 Unknown  Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®

Study has passed its completion date and status has not been verified in more than two years.